Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: 201306086 Principal Investigator: Waqar, Saiama
Title: A Randomized, Open-Label Phase 2 Study Evaluating LY2875358 Plus Erlotinib and LY2875358 Monotherapy in MET Diagnostic Positive NSCLC Patients with Acquired Resistance to Erlotinib
Phase: II Disease Site: Lung
Participating Site(s):
 
Main Campus
Map and Directions
South County
Map and Directions
St. Peters
Map and Directions
West County
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu

Description:
The primary purpose of this study to see how safe LY2875358 is and how well can control non small cell lung cancer (NSCLC) that has spread to other places in the body.
 
More Information:
ClinicalTrials.Gov Link
Internal Protocol Documents (requires Siteman administrative database password)